Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move: Interview
with CEO of Strainprint Technologies at ICBC
Conference in Vancouver @IntlCBC
Delta, Kelowna, BC –September 20, 2019
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at
https://www.investorideas.com/news/2019/cannabis-potcasts/09201Interview-StrainprintTechnologies.asp
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts
In
today’s podcast I interview Andrew
Muroff, CEO of StrainprintTM Technologies, the leader in
demand-side cannabis data and analytics, at the ICBC Conference in Vancouver. We discussed some of the data
trends being noticed through Strainprint as well as the potential future uses
of this technology and data.
StrainprintTM was created by patients for patients
with a mission to advance the scientific understanding of cannabis and its
legitimization as a mainstream therapy. StrainprintTM is aslo privacy compliant,
military-grade encrypted and all patient data is completely anonymized and at
rest in Canada.
When discussing who is showing interest
in Strainprint’s data and analytics, Andrew commented on the company’s most
recent news with Health Canada. “I’m very proud to report that after a long
discussion period we now have Health Canada as a customer looking at our data.
So we now have Health Canada looking at the data, as well as various medical associations,
some of the largest producers and pharmacies all looking at our data and our
technology.”
Not only are patients and practitioners
utilizing the company's data but Andrew also commented on the interest of
producers as well. “As an example, a licensed producer can’t go to a doctor and
say my product does this, they can’t make a claim. But what they can say is,
3000 patients have used my product 60,000 times on Strainprint and this is what
they said. That type of data, while it is patient reported, it’s real time and
it’s very accurate when you're thinking about the tens of thousands of users
and millions of reported outcomes.”
Andrew continued to discuss the changing
attitude of producers in the Canadian market saying, “we started to see great
traction in late 2018. Then the legalization of recreational cannabis sort of
through a wrench in a bunch of things. Producers kind of got caught in asking
“do we sell medical or do we sell recreational” and there wasn’t enough supply
so they were taking medical supply and putting it in recreational. Now we’re
seeing that they understand the effect that’s had on margins. They’re all
coming back around now and are all starting to realize they have the ability to
look beyond just POS data, but to be able to see what other producers are
selling and what might be better from a competitor then what you’re producing.”
Andrew also discussed the company’s
interest in international expansion stating, “we’ve already begun to look
elsewhere. The product is privacy compliant in both Canada and the U.S. and we
are about to be privacy compliant in Europe. We will be the only ones who are
privacy compliant in Europe. We are very
actively engaged in discussions in Germany and the U.K. We have also started a
foray into the U.S. As you know in the U.S., each state is an island so we are
going state by state. Florida is our first state and we have big traction there
and are now beginning to track Florida products. But we are very cautious about
the U.S. Not because we don’t think it’s going to be a great opportunity, just
because it’s a big investment for a small company like us to make if we’re
unsure about the market.”
Strainprint recently began putting out
their new product Strainprint Reports and Andrew discussed what we can
look forward to in the coming months. “We’re just launching right now, what we
call Strainprint Reports. It’s another way for us to leverage the data that
we’ve captured and you can expect to see a bunch of these out in the market
very soon. The first reports that we put out were symptom specific. The first
one was on insomnia, so looking at our data right now around sleep symptoms.
We’ve also published a report on those patients who use cannabis in addition to
polypharmacy, meaning more than one pharmaceutical, and seeing how that has
affected their experience. The big one that’s coming out now is the Canadian
Medical Cannabis Exp[experience, basically the retrospective on 800,000 patient
reported outcomes. It’s a big report and will be released in two weeks”
You can find out more information
regarding Strainprint Technologies here. https://strainprint.ca/
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment